/ /

Eric D. Donnenfeld, MD
Topical integrin antagonist lifitegrast safely treats dry eye disease
Lifitegrast ophthalmic solution 5.0% (Shire Pharmaceuticals) administered twice daily for 1 year appeared safe and well-tolerated with no unexpected adverse events in a study.
Natural oral omega-3 supplement improves dry eye parameters in 3 months
The natural triglyceride form of omega-3 is an excellent treatment option for dry eye disease.


View Results